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The ultimate goal of our research is the regulation of cellular functions by designed peptides and proteins. Current 
research subjects include (1) development of novel intracellular delivery systems aiming at elucidation and control of 
cellular functions using designed membrane permeable peptide vectors, (2) elucidation of the DNA binding modes of 
zinc finger proteins and TALEs, and design of artificial transcription factors with various DNA binding specificities, (3) 
elucidation and control of membrane curvature, and (4) design of 
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Topics
Controlling Leucine-Zipper Partner 
Recognition in Cells through Modification of 
a–g Interactions
The establishment of peptides that specifically inhibit 
protein interactions has been one of the major challenges in 
chemical biology. Selection of peptides from sophisticatedly 
designed libraries is one of the promising approaches 
in order to obtain peptides that strongly bind the target 
proteins. We have focused on the inhibition of a protein from 
the human T-lymphotropic virus type I (HTLV-1) known to 
cause adult T-cell leukemia (ATL). ATL is a peripheral T-cell 
neoplasm associated with infection by HTLV-1. The viral 
genome encodes the HTLV-1 bZIP factor (HBZ) known 
to promote T-cell proliferation and systemic inflammation. 
HBZ has a cFos-like leucine-zipper segment, which confers 
interaction of HBZ with cJun and related leucine-zipper 
proteins. Peptides that specifically block the interaction of 
HBZ with Jun related proteins could be powerful tools to 
elucidate the role of the interaction in the onset of ATL. By 
focusing on the a–g interactions, we successfully obtained 
a leucine-zipper segment that discriminates the appropriate 
partner over another that provides very similar patterns of 
electrostatic interactions (Figure 1).
Creating a TALE Protein with Unbiased 5’-T 
Binding
Artificial DNA binding proteins binding to desired DNA 
sequences are useful to control transcription of various 
genes and/or gene editing. So, they can be powerful tools 
for synthetic biology. Transcription activator-like effectors 
(TALEs) are sequence-specific DNA binding proteins 
secreted by the bacterial pathogen Xanthomonas. Though 
TALEs have the target sequence versatility determined by 
tandem repeats regions, almost all TALE binding sites are 
preceded by a highly conserved 5’ terminal T nucleotide. An 
N-terminal noncanonical repeat (Repeat -1) has been thought 
to interact specifically with the 5’-T. We performed directed 
evolution of the repeat to bind to non 5’-T sequences using 
a bacterial 1-hybrid assay (Figure 2). The selected mutants 
showed significantly strong DNA binding activity to the 
binding sites starting from non 5’-T.
Molecular Interplays Involved in the Cellular 
Uptake of Octaarginine on Cell Surfaces and 
the Importance of Syndecan-4 Cytoplasmic V 
Domain for the Activation of Protein Kinase Cα
Arginine-rich cell-penetrating peptides (CPPs) are promis-
ing carriers for the intracellular delivery of various bioactive 
molecules. However, many ambiguities remain about the 
molecular interplays on cell surfaces that ultimately lead 
to endocytic uptake of CPPs. By treatment of cells with 
octaarginine (R8), enhanced clustering of syndecan-4 on 
plasma membranes and binding of protein kinase Cα (PKCα) 
to the cytoplasmic domain of syndecan-4 were observed; 
these events potentially lead to the macropinocytic uptake 
of R8. The cytoplasmic V domain of syndecan-4 made a 
significant contribution to the cellular uptake of R8, whereas 
the cytoplasmic C1 and C2 domains were not involved in 
the process.
Figure 1. Designing an HBZ specific peptide without interfering with Jun–
Fos recognition in cell.
Figure 3. Schematic diagram of Syn-4 clustering and binding to PKCα inside 
cells induced by arginine-rich peptides.
Figure2. Directed evolution of TALE repeat-1 for recognition of non 5’-T.
